e-Posters
- Abstract 21015: Mother–adolescent communication on maternal breast cancer
- Abstract 21017: An exploratory study of fulvestrant in combination with oral vinorelbine for hormone receptor positive, HER2 negative relapsed or metastatic breast cancer
- Abstract 21028: De-escalating treatment for ductal carcinoma in situ - has the pendulum swung too far?
- Abstract 21035: Towards establishing extracellular vesicle-associated RNAs as biomarkers for HER2+ breast cancer
- Abstract 21042: Platelets and breast cancer: implications for clinical and pharmaceutical practice
- Abstract 21055: Gail's model - locally adapted and expanded for New Zealand? An example that in the Czech Republic a similar model works very well
- Abstract 21056: High risk of false positive tumor markers in breast and ovarian cancers during the covid-19 pandemic time
- Abstract 21057: CD82 as a potential molecular target in triple negative breast cancer: a pilot study
- Abstract 21059: Establishing the role of cholesteryl ester transfer protein (CETP) in breast cancer
- Abstract 21078: Resistance to anti-HER2 therapy associated with TSC2 nonsynonymous variant c.4349C>G (p. Pro1450Arg) is rescued by CDK4/6 inhibitor in HER2-positive breast cancer
- Abstract 21079: BRCANet: a deep hybrid network in predicting BRCA1/2 germline mutations in breast cancer patients with dynamic contrast-enhanced breast MRI
My anchor
Abstract 21015
Title: Mother–adolescent communication on maternal breast cancer
Presenter: Rei Oshiro
Affiliation: Department of Family Nursing, Division of Health Sciences and Nursing, Graduate School of Medicine, University of Tokyo; Department of Nursing, School of Nursing, Hyogo University of Health Sciences, Hyogo, Japan
Back to Top
My anchor
Abstract 21017
Title: An exploratory study of fulvestrant in combination with oral vinorelbine for hormone receptor positive, HER2 negative relapsed or metastatic breast cancer
Presenter: Peng Yuan
Affiliation: National Cancer Center/National Clinical Research Center For Cancer/Cancer Hospital, Beijing, China
Back to Top
My anchor
Abstract 21028
Title: De-escalating treatment for ductal carcinoma in situ - has the pendulum swung too far?
Presenter: Michael Co
Affiliation: Department of Surgery, LKS Faculty of Medicine, University of Hong Kong, Hong Kong SAR
Back to Top
My anchor
Abstract 21035
Title: Towards establishing extracellular vesicle-associated RNAs as biomarkers for HER2+ breast cancer
Presenter: Euphemia Leung
Affiliation: Auckland Cancer Society Research Centre, University of Auckland, Auckland; Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, Auckland, New Zealand
Back to Top
My anchor
Abstract 21042
Title: Platelets and breast cancer: implications for clinical and pharmaceutical practice
Presenter: Ali Tafazoli
Affiliation: Department of Clinical Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Back to Top
My anchor
Abstract 21055
Title: Gail's model - locally adapted and expanded for New Zealand? An example that in the Czech Republic a similar model works very well
Presenter: Ladislav Pecen
Affiliation: Department of Immunochemistry Diagnostics, University Hospital, Pilsen, Czech Republic; Faculty of Medicine, Charles University, Pilsen, Czech Republic; Institute of Computer Science of the Czech Academy of Science, The Czech Academy of Science, Prague, Czech Republic
Back to Top
My anchor
Abstract 21056
Title: High risk of false positive tumor markers in breast and ovarian cancers during the covid-19 pandemic time
Presenter: Ondrej Topolcan
Affiliation: Department of Immunochemistry Diagnostics, University Hospital; Faculty of Medicine, Charles University, Pilsen, Czech Republic
Back to Top
My anchor
Abstract 21057
Title: CD82 as a potential molecular target in triple negative breast cancer: a pilot study
Presenter: Maximillian Viera
Affiliation: Department of Anatomy, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117594, Singapore
Back to Top
My anchor
Abstract 21059
Title: Establishing the role of cholesteryl ester transfer protein (CETP) in breast cancer
Presenter: Liang Gu
Affiliation: Department of Molecular and Cell Biology, University of Witwatersrand, South Africa
Back to Top
My anchor
Abstract 21078
Title: Resistance to anti-HER2 therapy associated with TSC2 nonsynonymous variant c.4349C>G (p. Pro1450Arg) is rescued by CDK4/6 inhibitor in HER2-positive breast cancer
Presenter: Wen-Ming Cao
Affiliation: Department of Breast Medical Oncology, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou 310022, China; Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences, Hangzhou 310022, China
Back to Top
My anchor
Abstract 21079
Title: BRCANet: a deep hybrid network in predicting BRCA1/2 germline mutations in breast cancer patients with dynamic contrast-enhanced breast MRI
Presenter: Li-Li Wang
Affiliation: Department of Breast Medical Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou 350014, China
Back to Top
My anchor
Contacts Information
Please do not hesitate to contact us by emailing nzbcs@aut.ac.nz for either becoming a sponsor of or participation/involvement in the NZBCS-2021 conference.Professor Ian Campbell
Vice President, NZABC® Inc.
Chair, the Scientific Committee, NZBCS-2021
A/Professor Dong-Xu Liu
President, NZABC® Inc.
Chair, the Organising Committee, NZBCS-2021
For any general queries regarding the NZBCS-2021, please contact Dr Holly Perry, the Secretary of the Organising Committee of NZBCS-2021, School of Science, the Auckland University of Technology. Tel: +64 (0)9 921 9999 ext. 8033. Email: holly.perry@aut.ac.nz.
My anchor
Forms and Documents
-
The NZBCS-2021 Sponsorship Prospectus can be downloaded here.
- The NZBCS-2021 Poster can be downloaded here.
- The Template and Example of Abstract can be downloaded here.
- The NZABC® Inc. Membership Application Form can be downloaded here.
- The NZABC® Inc. Donation Form can be downloaded here.
- The Rules and Articles of NZABC
- The Rules and Articles of NZABC® Inc. can be downloaded here.
